Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan K Shields

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Antimicrobial Agents and Chemotherapy|February 28, 2016
Erratum for Shields et al., Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream InfectionRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2016
Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic FibrosisHongfei Zhang, M Hong Nguyen, Cornelius J Clancy, et al.
International Journal of Antimicrobial Agents|December 12, 2024
Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infectionsSunish Shah, Kathleen Adams, Lloyd Clarke, et al.
Msphere|March 16, 2026
Within-patient evolution of <i>Pseudomonas aeruginosa</i> populations during antimicrobial treatmentGiuseppe Fleres, Ellen G Kline, Kevin M Squires, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream InfectionRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
The changing epidemiology and long-term outcomes of patients with CRE infectionsSunish Shah, Lloyd G Clarke, Erin K McCreary, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2014
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypesCornelius J Clancy, Binghua Hao, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrataRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2024
Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemiaDeborah A Theodore, Amrita D Henneman, Angela Loo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017Ahmed Babiker, Lloyd G Clarke, Melissa Saul, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|February 28, 2016
Erratum for Shields et al., Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream InfectionRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2016
Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic FibrosisHongfei Zhang, M Hong Nguyen, Cornelius J Clancy, et al.
International Journal of Antimicrobial Agents|December 12, 2024
Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infectionsSunish Shah, Kathleen Adams, Lloyd Clarke, et al.
Msphere|March 16, 2026
Within-patient evolution of <i>Pseudomonas aeruginosa</i> populations during antimicrobial treatmentGiuseppe Fleres, Ellen G Kline, Kevin M Squires, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream InfectionRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
The changing epidemiology and long-term outcomes of patients with CRE infectionsSunish Shah, Lloyd G Clarke, Erin K McCreary, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2014
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypesCornelius J Clancy, Binghua Hao, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2012
The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrataRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2024
Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemiaDeborah A Theodore, Amrita D Henneman, Angela Loo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2020
Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017Ahmed Babiker, Lloyd G Clarke, Melissa Saul, et al.
Pageof 20